THC (Marijuana) Test Evidence
Has Caused a False Positive
Methoxyisoflavone
Source Methoxyisoflavone and urine cannabinoid screening: evidence of a poorly known…, 2012
What It Found
- A bodybuilding supplement produced positive cannabinoid screens in three volunteers after repeated doses.
Keep in Mind
- The study involved one synthetic isoflavone and three volunteers.
- The findings do not apply to dietary soy isoflavones.
Test Studied
- Urine cannabinoid screen in a supplement administration study
Both sources Methoxyisoflavone and urine cannabinoid screening: evidence of a poorly known…, 2012 Lecompte et al., J Pharm Biomed Anal 2014
What It Found
- Analysis identified the 5-methyl-7-hydroxyisoflavone metabolite.
Ibuprofen
Source Rollins et al., Clin Chem 1990
What It Found
- A prospective study of 510 urine samples from 102 NSAID users found one false-positive cannabinoid result after a total of 1,200 mg taken over one day and one with a different NSAID.
Keep in Mind
- This was an isolated observation on an older method.
- It offers little basis for predicting what will happen on a current assay.
Test Studied
- Older cannabinoid enzyme-mediated immunoassay (1990)
Naproxen
Source Rollins et al., Clin Chem 1990
What It Found
- A prospective study of 510 urine samples from 102 NSAID users found one false-positive cannabinoid result in a patient taking naproxen regularly and one with a different NSAID.
Keep in Mind
- This was an isolated observation on an older method.
- It offers little basis for predicting what will happen on a current assay.
Test Studied
- Older cannabinoid enzyme-mediated immunoassay (1990)
Cannabinol
Source Kroner et al., J Appl Lab Med 2020
What It Found
- Cannabinol added to urine reacted on both assays.
- It also increased the signal in samples containing small amounts of actual THC metabolite.
Keep in Mind
- The experiments tested urine in the laboratory.
- Cannabinol and cannabidiol are different ingredients.
Test Studied
- EMIT II Plus and Microgenics MultiGent urine cannabinoid immunoassays
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.92% relative response to Cannabinol.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS cannabinoids urine application on cobas c 501, Table 4
Raltegravir
Source Hughey and Colby, Clin Chem 2019
What It Found
- Drug-free urine spiked with raltegravir reached the cannabinoid screening cutoff at an estimated 339.5 micrograms/mL.
Keep in Mind
- This is a laboratory concentration.
- The study did not establish the chance of a positive urine test after a usual dose.
Test Studied
- Abbott MULTIGENT urine cannabinoid immunoassay, 50 ng/mL cutoff
Rotigotine
Source Hughey and Colby, Clin Chem 2019
What It Found
- Drug-free urine spiked with rotigotine reached the cannabinoid screening cutoff at an estimated 415.1 micrograms/mL.
Keep in Mind
- This is a laboratory concentration.
- The study did not establish the chance of a positive urine test after a usual dose.
Test Studied
- Abbott MULTIGENT urine cannabinoid immunoassay, 50 ng/mL cutoff
Depends on the Brand of Test
Cannabidiol
Source Sholler et al., J Anal Toxicol 2022
What It Found
- Pure CBD did not convert to THC in a controlled study that included prescription cannabidiol.
Source Wolf et al., J Anal Toxicol 2023
What It Found
- In a separate spiking study, six cannabinoid kits did not react to CBD itself, although some reacted to its 6-hydroxy or 7-hydroxy metabolites.
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.08% relative response to Cannabidiol.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS cannabinoids urine application on cobas c 501, Table 4
4 sources Sholler et al., J Anal Toxicol 2022 Wolf et al., J Anal Toxicol 2023 Yates et al., J Anal Toxicol 2025 Hart et al., J Anal Toxicol 2022
Keep in Mind
- A single administration study and spiked urine do not establish what every CBD dose or kit will do.
Test Studied
- Urine THC immunoassays and targeted LC-MS/MS
2 sources Sholler et al., J Anal Toxicol 2022 Hart et al., J Anal Toxicol 2022
Keep in Mind
- Products containing THC present a separate explanation.
Efavirenz
Source Oosthuizen and Laurens, Ann Clin Biochem 2012
What It Found
- Among 30 people taking efavirenz, 28 samples reacted on Rapid Response strips.
- All 30 were negative by GC-MS and on the three comparison immunoassays.
Test Studied
- Rapid Response Drugs of Abuse strip, THC One Step, Roche Cannabinoids II and Beckman Coulter SYNCHRON THC2
2 sources Oosthuizen and Laurens, Ann Clin Biochem 2012 Rossi et al., Clin Chem 2006
What It Found
- The findings implicated a glucuronidated efavirenz metabolite.
Keep in Mind
- Results varied by product even among rapid tests.
Source Koh et al., Med J Malaysia 2013
What It Found
- In a separate AxSYM study, 50 of 51 efavirenz-treated participants screened negative.
- The one who screened positive reported using cannabis the previous day.
Test Studied
- Abbott AxSYM Cannabinoids
Source Sustiva yields false positives on marijuana tests, 1998
What It Found
- A historical drug bulletin reported that the manufacturer had observed unconfirmed THC screens during efavirenz use.
Keep in Mind
- The notice gives no assay and no experimental data.
Test Studied
- 1998 manufacturer's account summarized by the Critical Path AIDS Project
3 sources Oosthuizen and Laurens, Ann Clin Biochem 2012 Rossi et al., Clin Chem 2006 Koh et al., Med J Malaysia 2013
Keep in Mind
- An efavirenz prescription alone cannot establish why an individual screen was positive.
Niflumic acid
Source Kovatsi et al., J Anal Toxicol 2010
What It Found
- All 55 urine specimens from five people receiving niflumic acid reacted on KIMS and were negative on EMIT.
- Spiking supported the same difference.
Keep in Mind
- These were repeated specimens from five people on two particular assays.
- The result should not be generalized to every drug test.
Test Studied
- KIMS and EMIT urine cannabinoid assays
Source Boucher et al., Arch Pediatr 2009
What It Found
- An earlier pediatric case had negative confirmatory chromatography.
Pantoprazole
Source Gomila et al., J Anal Toxicol 2017
What It Found
- All eight pediatric samples collected at the start of pantoprazole treatment screened positive on Alere Triage.
- One reacted on KIMS and none on DRI.
- Pantoprazole also reacted on Alere in spiked urine.
Keep in Mind
- Clinical samples were small, and pure pantoprazole reacted on Alere only at high concentrations.
Test Studied
- Alere Triage TOX, KIMS Cannabinoids II, DRI Cannabinoids
2 sources Powers et al., Pain Med 2018 Vohra et al., Clin Toxicol (Phila) 2020
What It Found
- Separate EMIT II Plus and THC One Step studies found no interference under their test conditions.
Source Felton et al., Pediatrics 2015
What It Found
- A pediatric case report described an unexpected cannabinoid screen after a dose of intravenous pantoprazole.
Keep in Mind
- One case is insufficient to establish causality or to generalize across other proton pump inhibitors and assay platforms.
Test Studied
- Urine cannabinoid immunoassay in a published pediatric case
3 sources Gomila et al., J Anal Toxicol 2017 Powers et al., Pain Med 2018 Vohra et al., Clin Toxicol (Phila) 2020
Keep in Mind
- A result depends on the kit.
- These studies do not establish a class effect for acid suppressants.
A Related Drug the Test Picks Up
Delta-10 THC
Source Wolf et al., J Anal Toxicol 2023
What It Found
- Delta-10 THC isomers reacted with urine tests aimed at delta-9 THC metabolite in laboratory experiments.
Keep in Mind
- This reflects exposure to a related cannabinoid.
- A broad cannabis screen cannot identify a particular isomer.
- The laboratory must verify that its definitive method distinguishes the compounds.
Test Studied
- Six commercial urine cannabinoid immunoassays
Source Patton et al., J Anal Toxicol 2025
What It Found
- In fortified urine the (6aR,9R) carboxy metabolite of delta-10 THC reacted at the delta-9 metabolite cutoff.
Keep in Mind
- All 77 authentic urines containing delta-10-THC-COOH also contained delta-9-THC-COOH, so the study could not isolate the cause in those patients.
Test Studied
- Beckman Coulter EMIT II Plus Cannabinoid immunoassay
Delta-8 THC
4 sources Wolf et al., J Anal Toxicol 2023 Mullen et al., J Anal Toxicol 2023 ElSohly et al., J Anal Toxicol 1990 Yates et al., J Anal Toxicol 2025
What It Found
- Delta-8 THC and its metabolites reacted with urine tests aimed at delta-9 THC metabolite in laboratory experiments.
Keep in Mind
- This reflects exposure to a related cannabinoid.
- A broad cannabis screen cannot identify a particular isomer.
- The laboratory must verify that its definitive method distinguishes the compounds.
Test Studied
- Commercial urine cannabinoid immunoassays, including Abbott TDx and antibody-based ELISA assays
Source Rosano et al., J Anal Toxicol 2023
What It Found
- The study showed how resolving delta-8- and delta-9-carboxy-THC isomers changes interpretation of cannabinoid confirmation.
Keep in Mind
- This result concerns confirmatory-method selectivity.
- A class screen cannot distinguish individual THC isomers.
Test Studied
- Urine confirmation by isomer-selective UPLC-MS/MS
Source Akpunonu et al., Am J Case Rep 2021
What It Found
- A child's urine screened positive after delta-8 THC gummies.
- Specialized testing confirmed delta-8 exposure in urine and serum.
Test Studied
- Hospital urine cannabinoid screen with specialized LC-QTOF-MS testing
Source Karas et al., J Anal Toxicol 2024
What It Found
- Nearly one-third of 2,939 immunoassay-positive urines contained delta-8 THC-COOH without delta-9 THC-COOH at the 15 ng/mL confirmation cutoff.
Keep in Mind
- The study population was selected for an already positive screen.
- The fraction is not the chance of testing positive after using delta-8.
Test Studied
- Urine cannabinoid immunoassay, cutoff 50 ng/mL, with isomer-selective LC-MS/MS
2 sources ElSohly et al., J Anal Toxicol 1990 Akpunonu et al., Am J Case Rep 2021
Keep in Mind
- A standard cannabinoid screen cannot determine which THC isomer someone used.
Hexahydrocannabinol
Source Tsujikawa et al., Forensic Toxicol 2025
What It Found
- Two carboxy-HHC isomers triggered three urine THC panels in spiking experiments.
- All three panels also reacted to a urine specimen from one reported HHC user.
Keep in Mind
- The response depended on the isomer and the device.
Test Studied
- Urine cannabinoid panels, including Driven Flow THC L50, IVeX-Screen THC L50-S and AccuSign THC
Source Lucuta et al., Forensic Sci Int 2025
What It Found
- Urine cannabinoid tests became positive after oral or inhaled HHC product exposure in the small self-administration study.
Keep in Mind
- The paper separately evaluated oral fluid and plasma.
- The urine result applies to the tested device and products.
Test Studied
- DrugScreen urine strip, 25 ng/mL THC-COOH cutoff
Source Höfert et al., Drug Test Anal 2024
What It Found
- The authors reported that the evaluated urine strips could detect HHC-related exposure, with performance dependent on the tested compound and device.
Keep in Mind
- The traffic series measured HHC in serum or plasma.
- It was separate from the urine strip experiments.
Test Studied
- Urine cannabinoid test strips included in a multi-matrix HHC evaluation
3 sources Helander et al., Scand J Clin Lab Invest 2024 Tsujikawa et al., Forensic Toxicol 2025 Yates et al., J Anal Toxicol 2025
Keep in Mind
- A class screen cannot distinguish HHC exposure from delta-9 THC exposure.
Also cited: Wolf et al., J Anal Toxicol 2023
Delta-8 tetrahydrocannabivarin
Source Sempio et al., Forensic Toxicol 2026
What It Found
- After healthy volunteers took delta-8 THCV, 70 of 80 pooled urine samples from the first eight hours screened positive.
- LC–MS/MS found no delta-9 THC carboxy metabolite in those samples and identified metabolites of delta-8 THCV.
Keep in Mind
- This was a controlled study of a related cannabinoid.
- The count refers to pooled samples, and the result cannot predict what other products or tests will show.
Test Studied
- Urine immunoassay targeting the delta-9 THC carboxy metabolite, with LC–MS/MS comparison
The Test Is Made to Find It
Dronabinol
Source Koch et al., Clin Chim Acta 2020
What It Found
- Five dronabinol-treated patients provided urine in which the study detected THC metabolites.
- The prescription medicine supplies delta-9 THC, the substance a cannabis test is designed to detect.
Keep in Mind
- A routine positive THC-metabolite result alone does not establish the source or show impairment.
Test Studied
- Urine cannabinoid metabolites measured by LC-MS/MS
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 1.3% for delta-9-THC, 14% for 11-hydroxy-THC and 34% for THC-COOH glucuronide relative response.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS cannabinoids urine application on cobas c 501, Table 4
CBD products containing delta-9 THC
Source Sholler et al., J Anal Toxicol 2022
What It Found
- After vaporized CBD-dominant cannabis containing measured delta-9 THC, three of 18 participants produced samples meeting the study’s confirmatory THC-metabolite cutoff.
- The product supplied real THC.
Keep in Mind
- The measured product and dose matter.
Test Studied
- Urine cannabinoid immunoassays and targeted LC-MS/MS
Source Goggin and Janis, Clin Toxicol (Phila) 2021
What It Found
- Some users of commercial CBD products excreted actual THC metabolites.
Keep in Mind
- Commercial formulations and histories vary.
- Urine alone cannot identify the specific product supplying the THC.
Test Studied
- Specific urine cannabinoid metabolite measurement in users of commercial CBD products
Both sources Sholler et al., J Anal Toxicol 2022 Goggin and Janis, Clin Toxicol (Phila) 2021
What It Found
- A positive urine result can therefore reflect THC exposure from the product.
Keep in Mind
- A label saying CBD alone does not tell how much THC was present.
A Problem With the Urine Sample
Baby wash contamination
Source Cotten et al., Clin Biochem 2012
What It Found
- Adding certain baby wash products to drug-free urine generated a THC screening signal.
- Investigators traced the effect to specific surfactants.
Keep in Mind
- This is a specimen-collection issue.
- The study did not find that bathing or skin contact produces THC metabolites in the body.
Test Studied
- Urine THC immunoassay in a newborn nursery investigation
Suspected, but Not Proven
Furosemide
Source Ayala-Lopez et al., J Anal Toxicol 2022
What It Found
- Patients with a record of furosemide use had more unconfirmed positive screens in one hospital study.
- Adding furosemide to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.
Keep in Mind
- A medication list records prior use.
- It cannot identify what was in a particular specimen or which substance produced a signal.
Test Studied
- Alere Integrated E-Z Split Key Cup II urine THC (cannabis or marijuana metabolites) screen
Meloxicam
Source Ayala-Lopez et al., J Anal Toxicol 2022
What It Found
- Patients with a record of meloxicam use had more unconfirmed positive screens in one hospital study.
- Adding meloxicam to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.
- Its 5′-carboxy metabolite also tested negative up to 800 micrograms/mL.
Keep in Mind
- A medication list records prior use.
- It cannot identify what was in a particular specimen or which substance produced a signal.
Test Studied
- Alere Integrated E-Z Split Key Cup II urine THC (cannabis or marijuana metabolites) screen
Tolmetin
Source Joseph et al., J Anal Toxicol 1995
What It Found
- On the older EMIT method, known-positive cannabinoid samples containing tolmetin could read negative.
Keep in Mind
- The mechanism and direction matter.
- An instrument error or depressed signal is not evidence of a false-positive screen.
- A separate high-concentration TDx benzodiazepine finding is indexed under benzodiazepines.
Tests Studied
- Older Syva EMIT on Hitachi 704
- Compared with Abbott TDx
Rifampin
Source la Porte et al., Ther Drug Monit 2006
What It Found
- A clinical drug reference lists rifampin.
- A phase 1 report involved efavirenz and rifampin, and the indexed record does not isolate a rifampin effect on the THC test.
Keep in Mind
- Efavirenz has separate urine cannabinoid evidence.
- Rifampin also has evidence on opiate assays that cannot establish THC interference.
Tests Studied
- Cannabinoid screen
- Reagent and independent rifampin challenge unverified
Tested: No False Positive Found
Hexahydrocannabiphorol
Source Schirmer et al., Drug Test Anal 2025
What It Found
- One volunteer’s urine had HHCP metabolites on mass spectrometry and negative cannabinoid immunoassays.
Keep in Mind
- One dose in one volunteer cannot establish nonreactivity of all HHCP products.
- HHCP and HHC are distinct substances.
Test Studied
- Urine enzyme immunoassays targeting delta-9 THC after one 4 mg oral HHCP dose
Source Höfert et al., Drug Test Anal 2024
What It Found
- The researchers reported no cross-reactivity for the HHC analogues HHC-O or HHC-P, or H4-CBD, on the tested devices.
Keep in Mind
- This refers to the compounds added in the laboratory.
- A product can contain additional cannabinoids, and metabolism may introduce other analytes.
Test Studied
- Study of commercial cannabinoid screens including urine test strips
Esomeprazole
Source Vohra et al., Clin Toxicol (Phila) 2020
What It Found
- Urine samples stayed negative in the volunteers assigned to esomeprazole after five days of oral treatment in a small study of proton pump inhibitors.
Keep in Mind
- Only one strip was used.
- Few people took each medicine and adherence was not independently verified.
Test Studied
- THC One Step Marijuana Test Strip
Lansoprazole
Source Vohra et al., Clin Toxicol (Phila) 2020
What It Found
- Urine samples stayed negative in the volunteers assigned to lansoprazole after five days of oral treatment in a small study of proton pump inhibitors.
Keep in Mind
- Only one strip was used.
- Few people took each medicine and adherence was not independently verified.
Test Studied
- THC One Step Marijuana Test Strip
Omeprazole
Source Vohra et al., Clin Toxicol (Phila) 2020
What It Found
- Urine samples stayed negative in the volunteers assigned to omeprazole after five days of oral treatment in a small study of proton pump inhibitors.
Keep in Mind
- Only one strip was used.
- Few people took each medicine and adherence was not independently verified.
Test Studied
- THC One Step Marijuana Test Strip
Acetaminophen
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Chocolate-associated ethanolamides
Source Tytgat et al., Int J Legal Med 2000
What It Found
- None of three chocolate-associated lipids produced a positive result when added to urine.
Keep in Mind
- This was a challenge with individual compounds, without an oral chocolate exposure group.
Test Studied
- Urine cannabinoid immunoassay challenged with anandamide, oleoylethanolamide and linoleoylethanolamide
Dextromethorphan
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Diphenhydramine
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Hexahydrocannabinol acetate
Source Höfert et al., Drug Test Anal 2024
What It Found
- The researchers reported no cross-reactivity for the HHC analogues HHC-O or HHC-P, or H4-CBD, on the tested devices.
Keep in Mind
- This refers to the compounds added in the laboratory.
- A product can contain additional cannabinoids, and metabolism may introduce other analytes.
Test Studied
- Study of commercial cannabinoid screens including urine test strips
Meprobamate
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Nabilone
Source Fraser and Meatherall, J Anal Toxicol 1989
What It Found
- The original publication reported no interference by nabilone with these urine cannabinoid methods.
- Nabilone and dronabinol are different medicines.
Keep in Mind
- These results apply to the evaluated methods.
- The relevant target on a routine cannabis report is a THC metabolite.
Test Studied
- EMIT d.a.u., Abbott TDx cannabinoid and a THC-metabolite TLC method
Prednisone
Source FDA 510(k) K253567. Healgen Accurate Urine Drug Screen Dip Card and Home Urine Drug Test…, 2025
What It Found
- Prednisone at 100 µg/mL did not cause a positive result in drug-free urine or change the result of urine just below or above this channel’s cutoff.
Keep in Mind
- The manufacturer challenged the assay with parent prednisone.
- This does not test all prednisone metabolites or predict the behavior of other devices.
Tests Studied
- Healgen Accurate multi-drug urine dip card
- The applicable target and cutoff are 50 ng/mL carboxy-THC
Tetrahydrocannabidiol
Source Höfert et al., Drug Test Anal 2024
What It Found
- The researchers reported no cross-reactivity for the HHC analogues HHC-O or HHC-P, or H4-CBD, on the tested devices.
Keep in Mind
- This refers to the compounds added in the laboratory.
- A product can contain additional cannabinoids, and metabolism may introduce other analytes.
Test Studied
- Study of commercial cannabinoid screens including urine test strips